Abstract 856: Number of ALK-amplified circulating tumor cells predicts progression-free survival in ALK-rearranged non-small cell lung cancer patients treated by crizotinib

Author(s):  
Emma Pailler ◽  
Marianne Oulhen ◽  
Kirsty Ross ◽  
Fanny Billiot ◽  
Nathalie Auger ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document